Business Context and Reporting Period
This Form 8-K filing by KVH Industries, Inc. (Delaware) reports on events occurring on February 28, 2008. The filing details compensatory arrangements approved by the Compensation Committee for the company's Named Executive Officers (NEOs), including 2007 cash bonuses, 2008 base salaries, and restricted stock awards.
Key Financial Metrics and Compensation Data
The filing does not provide consolidated revenue, profit, cash flow, margin, debt, or liquidity metrics for the company. It focuses exclusively on executive compensation figures:
| Executive | Title | 2007 Bonus | 2008 Base Salary | Restricted Stock (Shares) |
|---|---|---|---|---|
| Martin A. Kits van Heyningen | President & CEO | $40,860 | $355,300 | 50,000 |
| Patrick J. Spratt | CFO | $23,535 | $235,350 | 25,000 |
| Ian C. Palmer | EVP, Satellite Sales | $14,468 | $206,690 | 15,000 |
| Robert J. Balog | VP, Engineering | $14,934 | $199,125 | 15,000 |
| Robert W.B. Kits van Heyningen | VP, R&D | $11,711 | $195,189 | 15,000 |
| A.H. Kits van Heyningen | Chief Scientist | $12,405 | $190,942 | 15,000 |
Material Changes and Compensation Structure
- 2007 Bonus Performance: Bonuses were awarded based on individual performance goals. Corporate performance goals for 2007 were not met, and no bonuses were earned for that portion.
- 2008 Base Salaries: No changes were made to base salaries compared to 2007.
- 2008 Bonus Formula: A new formula was approved where 75% of the bonus is tied to corporate performance (EPS) and 25% to individual goals. The corporate portion uses a sliding scale:
- Threshold: 60% of target EPS earns 30% of the target bonus.
- Maximum: 155% of target EPS earns 200% of the target bonus.
Outlook, Risks, and Unusual Items
Restricted Stock Vesting Conditions: The 2008 restricted stock awards have specific vesting terms:
- 50% of the grant vests annually in four equal installments starting February 28, 2009.
- The remaining 50% vests annually in four equal installments starting February 28, 2009, provided that:
- Company revenue for the year ending December 31, 2008, is at least 20% higher than the prior year.
- The executive remains employed at the time of vesting.
Unusual Item: A.H. Kits van Heyningen (Chief Scientist) is currently on medical leave. His restricted stock award will be delivered upon his return to active employment.
Investor Verification Checklist
- Verify the company's actual 2007 revenue to assess the feasibility of the 20% growth target required for partial restricted stock vesting.
- Review the company's 2008 earnings per share (EPS) targets to understand the potential payout range for the new corporate performance bonus formula.
- Monitor the status of A.H. Kits van Heyningen's medical leave and return to active employment.
- Confirm that no corporate performance bonuses were paid for 2007 as stated in the filing.